Clinical Trial Update: An EEG Study of Intravenous Ketamine for Major Depression Disorder [Phase 4]

View source ↗

Summary

Clinical trial update for intravenous ketamine in major depressive disorder (Phase 4) with unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Ketamine (intravenous) (ketamine)

Snippet

Sponsor: Ehave Inc. | Conditions: Major Depressive Disorder | Phase 4 | Status: UNKNOWN